Home Archive
Archive
2023 Volume 44 Issue 1  Published: 2023-01-10
    Topic
  • Yi ZHU , Dingkun GUI , Niansong WANG
    doi: 10.13683/j.wph.2023.01.001

    Glucagon-like peptide-1 receptor agonist (GLP-1RA) is a novel hypoglycemic agent with a variety of targets. It is widely used in the treatment of diabetic nephropathy (DN), which is characterized by improving oxidative stress and anti-inflammatory effects, alleviating damage of advanced glycosylation end-products, regulating renin-angiotensin-aldosterone system, improving endothelial function, alleviating renal fibrosis, and playing a protective role in the kidney. This paper reviewed the literatures published in recent years on the clinical application and mechanism of GLP-1RA in the treatment of DN, so as to provide reference for clinical practice.

  • Topic
  • Sijie GU , Ying FAN , Niansong WANG
    doi: 10.13683/j.wph.2023.01.002

    Diabetic nephropathy (DN) is a chronic microvascular complication of diabetes mellitus (DM), which is also the main cause of end-stage renal disease (ESRD). The prevalence rate of DM related chronic kidney disease (CKD) has exceeded that of glomerulonephritis (GN) related CKD. DN has become a big social problem for Chinese residents. The main treatment options for DN are lifestyle change and drug therapy, but currently common drugs can only reduce symptoms and delay disease progression, and new drugs are needed to improve the overall outcome of DN patients. Endothelin receptor antagonist (ERA), a new class of drugs used in DN in recent years, has shown good effects. This article summarized the clinical research progress of ERA in the treatment of DN, aiming to provide reference for clinical practice.

  • Topic
  • Wei ZHANG , Ying FAN , Niansong WANG
    doi: 10.13683/j.wph.2023.01.003

    Over activation of mineralocorticoid receptor (MR) can lead to the progression of chronic kidney disease (CKD). Finerenone, a novel MR antagonist with a non-steroidal structure, which is able to bind to MR with a unique mechanism to inhibit the recruitment of transcriptional cofactors involved in gene expression. It can effectively delay the progression of diabetic nephropathy (DN). This article reviewed the mechanism of action, evidence- based evidence, adverse reactions, combined application with sodium-glucose linked transporter-2 inhibitor of the novel finerenone in the treatment of DN, and its future prospects. The aim is to provide a new strategy for clinical treatment of DN.

  • Topic
  • Bingbing ZHU , Ying FAN , Niansong WANG
    doi: 10.13683/j.wph.2023.01.004

    Sodium-glucose linked transporter 2 inhibitor (SGLT-2i) is a new type of oral hypoglycemic agents. They can lower blood pressure, reduce uric acid, reduce body weight and reduce cardiac and renal adverse events by promoting urinary glucose and sodium excretion in renal tubules. SGLT-2i is one of the hot topics in the treatment of diabetes mellitus (DM) in recent years, which can effectively delay the progression of diabetic nephropathy (DN). This article reviewed the mechanism of action, clinical benefits, safety and guideline update of SGLT-2i in the treatment of DN, in order to provide new strategies for clinical treatment.

  • Topic
  • Jun TAO , Dongsheng CHENG , Niansong WANG
    doi: 10.13683/j.wph.2023.01.005

    Diabetic nephropathy (DN) is one of the most common complications in patients with diabetes mellitus (DM), which is mainly treated by medication in clinic. Oral hypoglycemic agents can not only optimize blood glucose control and reduce the risk of hypoglycemia, but also affect the progression of DN. Among them, dipeptidyl peptidase-4 inhibitor (DPP-4i) is an oral hypoglycemic agent that plays a role in changes in the level of the incretin system. DPP-4i showed additional pleiotropic effects in vitro models, including reduced inflammation, fibrosis and oxidative damage, further indicating a potential renal protective effect. DPP-4i may help delay DN progression, but further studies are needed to prove their specific benefit to the kidney. This article reviewed the biological function of DPP-4i, the mechanism on DN, and the clinical efficacy, in order to provide new ideas for clinical treatment.

  • Article
  • Lu LEI , Qingchun HE , Yi YANG
    doi: 10.13683/j.wph.2023.01.006
    Objective

    To investigate the ameliorative effect of zanthoxylin on inflammatory pain and its regulatory mechanism.

    Methods

    The general pain model and formaldehyde pain model of Kunming mice were established, and the effects of zanthoxylin on the two pain models were compared. The number of autonomous activities of the two model mice was recorded, and the levels of inflammatory factors were detected. The inhibitory effect of α7 nicotinic acetylcholine receptorα(7nAChR) antagonist on analgesia of zanthoxylin was analyzed, and the changes of JAK2 and STAT3 protein expression after α7nAChR antagonist blocking zanthoxylin were determined by western blotting.

    Results

    In the general pain model, the pain threshold of mice increased from (17.2±4.8) s to (30.3±9.2) s, and the increase rate increased from (43.3±1.3)% to (161.5±8.9)% 1 h after injection of zanthoxylin. The pain threshold of mice was increased from (15.8±5.4)s to (30.6±7.5)s, and the increase rate was increased from (31.7±2.5)% to (158.7±9.8)% 2 h after injection of zanthoxylin. In the formaldehyde-induced pain model, there was no significant difference in the duration of foot licking behavior between the control group and the zanthoxylin group in the phase Ⅰ acute pain stage, but the duration of foot licking behavior in the phase Ⅱ chronic pain stage was shortened in a dose-dependent manner. After the injection of zanthoxylin, the number of spontaneous activities of the general pain model mice decreased from (198.2±71.8) times to (102.0±48.5) times, while the number of spontaneous activities of the formaldehyde nociceptive pain model decreased from (207.5±80.1) times to (110.5±40.8) times. The expression levels of tumor necrosis factor (TNF)-α and interleukin (IL)-6 in the two pain model mice decreased and the expression level of IL-10 increased in a dose-dependent manner after injection of zanthoxylin. The protein expression levels of JAK2 and STAT3 were up-regulated.

    Conclusion

    Zanthoxylin can increase the pain threshold, shorten the duration of pain behavior and reduce the number of autonomous activities in mice. Its regulatory mechanism may be zanthoxylin binds to the α7nAChR receptor, and then activate JAK2/STAT3 signaling pathway to exert analgesic and anti-inflammatory effects.

  • Article
  • Xia TANG , Taibing DENG , Gang QING , Wanxiu HUANG , Xinfang MEI
    doi: 10.13683/j.wph.2023.01.007
    Objective

    To evaluate the effect of Maxing Shigan Decoction assisted western medicine treatment on peripheral blood T helper cell 17/regulatory T cell (Th17/Treg) balance in elderly patients with multi-drug-resistant bacteria (MORDs) hospital-acquired pneumonia (HAP), and provide strong evidence-based medical support for its clinical application.

    Methods

    A total of 130 elderly patients with MDROs-HAP in the respiratory emergency department and ICU inpatient department of our hospital from July 2019 to April 2021 were selected as the research objects and randomly divided into study group and control group, with 65 cases in each group. The control group was given standard Western medicine treatment, and the research group was supplemented with maxing Shigan decoction on the basis of standard Western medicine treatment. The percentage of Th17 (Th17%) and Treg (Treg%), Th17/Treg ratio, the levels of serum interleukin-17 (IL-17), IL-6, IL-10, C-reactive protein, procalcitonin (PCT) in 2 groups were detected. The clinical efficacy and incidence of adverse reactions were compared between the two groups.

    Results

    After treatment, the levels of serum PCT, IL-6, IL-17, Th17%, Th17/Treg ratio, total traditional chinese medicine syndrome score and acute physiology and chronic health evaluation scoring system Ⅱ in study group were all lower than those before treatment or in control group, while the level of serum IL-10 was higher than that before treatment and the control group (P<0.05). The curative effect of TCM syndrome in study group was better than that in control group (73.85% vs 52.31%, χ2=6.474, P=0.011). There was no significant difference in the total incidence of adverse reactions between the two groups (P>0.05).

    Conclusion

    Maxing Shigan Decoction can significantly improve Th17/Treg cell imbalance and immune dysfunction in elderly patients with MDROs-HAP, and significantly reduce the level of serum inflammatory factors, so as to effectively and safely improve the clinical efficacy of patients, worthy of clinical promotion.

  • Article
  • Wenjuan MA , Qi SU , Yuyu QIAO , Jing CHEN , Xueyan LI
    doi: 10.13683/j.wph.2023.01.008
    Objective

    To observe the effect of Chunru gel combined with policresulen solution on vaginal microecology and inflammatory factors in patients with chronic cervicitis.

    Methods

    A total of 246 patients with chronic cervicitis admitted to Northwest Women's and Children's Hospital from November 2018 to October 2021 were divided into control group and test group according to the simple randomization method, with 123 cases in each group. The control group was treated with policresulen solution, and the test group was treated with Chunru gel on the basis of the control group for four consecutive weeks. The total effective rate of the two groups was compared. The levels of inflammatory factors, vaginal micro ecological indicators and adverse reactions in the two groups were observed before and 4 weeks after treatment.

    Results

    After 4 weeks of treatment, the total effective rate of the test group was 95.93%, higher than 85.37% of the control group (P<0.05). Serum tumor necrosis factor-β and interleukin (IL)-17 levels of the test group were all lower than those of the control group (P<0.05), and IL-23 levels was higher than that of the control group (P<0.05). The abnormal cleanliness of vaginal microecology, the positive rate of hydrogen peroxide and the positive rate of leukocyte lipase in the two groups were lower than those before treatment, and the test group was lower than the control group, the difference was statistically significant (P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05).

    Conclusion

    Chuangru gel combined with policresulen solution has a significant effect on the treatment of chronic cervicitis, which can reduce inflammatory response and improve vaginal microecological indicators.

  • Article
  • Jiahua LENG , Ziyi LIN , Jianwei XUAN
    doi: 10.13683/j.wph.2023.01.009
    Objective

    To estimate the potential health benefits of pembrolizumab for the second-line esophageal squamous cell carcinoma patients with programmed death-ligand 1 positive [combined positive score (CPS)≥10] in China from 2021 to 2025, in order to provide reference for scientific evaluation of clinical benefits of innovative antitumor drugs and effective allocation of health resources.

    Methods

    A patient flow calculation model and a partitioned survival model were built to calculate the number of patients with second-line esophageal squamous cell carcinoma who might be treated with pembrolizumab from 2021 to 2025. A partitioned survival model was established to estimate the incremental benefits of life year (LY) and quality-adjusted life years (QALYs) gained of an average patient using pembrolizumab compared with regular chemotherapies. The total potential gains in LY and QALYs of the second-line esophageal squamous cell carcinoma patients in China from 2021 to 2025 was calculated by discounting at 5% annually.

    Results

    In the next 5 years, a total of 43 439 patients could benefit from pembrolizumab. The average lifetime LY and QALYs increments per patient with pembrolizumab are 1.603 and 1.442, respectively. The total increments of LY and QALYs in 5 years gained by the introduction of pembrolizumab were 63 026 and 56 696, respectively.

    Conclusions

    Programmed death-1 inhibitor is expected to bring considerable survival and quality-of-life benefits for patients with esophageal squamous cell carcinoma in China.

  • Article
  • Lisa JIN , Bin PENG , Dayu WU , Xuelian YANG , Xiaowen ZHOU , Longxuan LI , Bincang HUANG , Wei CHEN
    doi: 10.13683/j.wph.2023.01.010
    Objection

    To investigate the correlation between plasma microRNAs (miR) and cerebral collateral circulation in patients with carotid stenosis.

    Methods

    In this cross-sectional study, 60 patients with carotid artery stenosis over 30% confirmed by ultrasound screening at Shanghai Gongli Hospital from Jan 2017 to Oct 2018 were enrolled. Cerebral digital subtraction angiography was used to evaluate the establishment of collateral circulation. Real-time fluorescence quantitative polymerase chain reaction was used to determine the expression levels of miR-92-3p, miR-15a-3p, miR-16-3p, miR-126-3p, miR-210-3p and miR-132-3p. The general clinical data, degree of carotid stenosis and the relationship between the establishment of cerebral collateral circulation and plasma miR level was compared among the three groups. Multivariate logistic regression and receiver operating characteristic curve (ROC) were used to analyze the predictive ability of plasma miR levels to establish cerebral collateral circulation in patients with carotid stenosis.

    Results

    According to the Guidelines for Evaluation and Management of Cerebral Collateral Circulation in Ischemic Stroke (2017) by the Chinese Medical Association, 17 cases were included in the 30% - 50% carotid stenosis group, 21 cases in the 50% - 70% carotid stenosis group, and 22 cases in the 70% - 99% carotid stenosis group. After adjusting for gender, drinking history and degree of carotid stenosis, logistic regression results showed that miR-92A-3p was negatively correlated with collateral circulation [(odds ratio, OR)=0.21]. miR-126-3p, miR-132-3p and miR-210-3p were positively correlated with collateral circulation (OR were 6.10, 1.91 and 3.09). ROC suggested that these four miR had predictive efficacy for collateral circulation establishment (area under curve: 0.918 - 0.942), among which miR-126-3p had the highest efficacy.

    Conclusion

    The expression levels of miR-92, miR-126, miR-210 and miR-132 in plasma have certain diagnostic value for establishing cerebral collateral circulation in patients with carotid stenosis.

  • Article
  • Hui PAN , Chenyang SHI , Guorong FAN , Yuanjun TANG
    doi: 10.13683/j.wph.2023.01.011
    Objective

    To investigate the distribution of blood concentration and liver and kidney function of tacrolimus in patients after liver transplantation.

    Methods

    The clinical data of 66 patients who underwent orthotopic liver transplantation in Shanghai General Hospital from September 2015 to October 2019 and were treated with tacrolimus regimen were retrospecticely collected, as well as the blood trough concentration of tacrolimus and liver and kidney function at different periods.

    Results

    The average blood concentration of tacrolimus in 66 patients whthin 30 days was (7.39±3.18) ng/ml, and 39% of patients had a blood concentration of 6—10 ng/ml. The average blood concentration in 90 days was (6.32±3.09)ng/ml, and 58% of patients had blood concentration was 4—8 ng/ml. The average blood concentration in 180 days was (6.43±3.03)ng/ml, and 55% of patients had blood concentration was 4—8 ng/ml, which was lower than the reference concentration of domestic guidelines. The alanine aminotransferase and aspartate aminotransferase in 66 patients gradually decreased to normal levels within 30 days after surgery, and remained basically within the normal range at 180 days after surgery, with no statistically significant difference compared with that before surgery. Serum creatinine (Scr) recovered within 30 days after surgery, but at D180 Scr was significantly higher than that before surgery, with statistical difference (P<0.05). In tacrolimus group, Scr was significantly different from that before operation at D180 (P<0.05). In tacrolimus+sirolimus group, Scr did not differ from that before surgery at D180.

    Conclusion

    Low tacrolimus effective concentration after liver transplantation can exert anti-rejection therapy and not cause adverse reactions. Long-term use of tacrolimus is associated with cumulative renal injury.

  • Article
  • Xiaoli SONG , Huiqin YANG , Yueliang XIE
    doi: 10.13683/j.wph.2023.01.012
  • Review
  • Yimei TAN , Yi ZHAO , Wei LIU , Yanyun MA
    doi: 10.13683/j.wph.2023.01.013

    The skin barrier is an important barrier system of the human body, which is crucial to the maintenance of body health, and its homeostasis is strictly and precisely regulated. Skin barrier damage is the main characteristic of problematic skin, as well as the key inducement and typical accompanying symptoms of a variety of skin diseases. An in-depth understanding of the formation and regulation mechanism of the skin barrier will not only help to establish repair strategies but also reveal the occurrence and development mechanism of related skin diseases. Therefore, this article reviewed on the skin barrier structure and regulation of the molecular mechanism. In the perspective of omics, this paper emphasized the research progress of barrier regulation related genomics, epigenomics, transcriptomics, proteomics and metabolomics, and summarized the target and strategy of barrier repair based on different omics levels, revealed the mechanism of barrier formation and the basis of repair, in order to provide a theoretical basis for the repair of the skin barrier and the precise prevention and control of related skin diseases.

  • Review
  • Wenqing ZHANG , Xuanxuan WANG , Anqi HUANG , Di XIE , Mengru XIN , Weizhi LIU , Hankun HU
    doi: 10.13683/j.wph.2023.01.014

    Traditional toxicological studies of drugs mostly focused on experimental animals. However, animal experiments were susceptible to many factors, and it was difficult to completely simulate the toxic reaction of drugs in human body, and there was a lack of sensitivity and specificity to predict drug toxicity. Organ-on- chip technology had attracted increasing attention by constructing heart, liver, kidney and other organ chips to carry out toxicological evaluation in vitro. In this paper, the research status, challenges and application prospects of the new technology in drug toxicological evaluation were reviewed, in order to provide reference for the development and application of this technology.

  • Review
  • Yang FU , Hongsheng WANG , Fengjuan LU
    doi: 10.13683/j.wph.2023.01.015

    Acute hematogenous osteomyelitis in children is the most common disease of skeletal muscle system infection in children. It is mainly caused by Staphylococcus aureus infection and has a strong destructive effect. Delayed treatment may lead to deep vein thrombosis, endocarditis and septic shock and other complications. In the long term, it may lead to bone ischemic necrosis, pathological fracture, deformity, activity restriction and affect growth and development and other sequelae. Therefore, early and accurate diagnosis and timely and reasonable treatment are very important. This article reviews the research progress in diagnosis and drug treatment of acute hematogenous osteomyelitis in children, in order to improve the standardization and therapeutic effect of treatment.

  • Pharmacy administration
  • Ning WANG , Yingyun GUAN , Xiaolan BIAN
    doi: 10.13683/j.wph.2023.01.016
    Objecitve

    To understand the current status of the application of sacubitril valsartan in hypertensive patients in China and evaluate its rationality in clinical application.

    Methods

    Through the prescription review system of the clinical pharmacy intelligent platform, all outpatient prescriptions with hypertension diagnosed and Sacubitril Valsartan used during the period from June 1 2021 to June 30 2022 were extracted, and the collected data were statistically and analyzed.

    Results

    A total of 17 100 qualified prescriptions were extracted. The top three departments in the number of prescriptions were hypertension department, cardiology department and nephrology department. Hypertension combined diseases were mainly cardiac insufficiency and renal insufficiency. Through the initial system screen and manual review, 1 033 unreasonable prescriptions were found, accounting for 6.04% of the total number of prescriptions. The main unreasonable problems were repeated drugs and the unreasonable use of combined drugs.

    Conclusion

    The population of application of Sacubitril Valsartan in hypertensive patients is increasing day by day, but the rationality of medication needs to be further improved. Pharmacists should strengthen the publicity and education of rational medication for doctors and patients to ensure the safety and effectiveness of new antihypertensive drugs in clinical application.

News